“HPV Vaccination and Allocative Efficiency: Regional Analysis of the Costs and Benefits With the Bivalent AS04-Adjuvanted Vaccine, from the Perspective of Public Health, for the Prevention of Cervical Cancer and Its Pre-Cancerous Lesions”. Farmeconomia. Health economics and therapeutic pathways 13, no. 2S (November 20, 2012): 3–15. Accessed October 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/449.